Sudarshan Pharma Industries Ltd — Important, 30-05-2026: Company Update

Sudarshan Pharma's Annual Secretarial Compliance Report for the financial year ended March 31, 2026, confirms the company's robust adherence to corporate governance standards and market regulations. The report indicates broad compliance across all applicable provisions. Notably, the company fully cooperated with BSE Limited during the period by providing clarifications on various financial parameters following an inquiry. This audit provides stakeholders with an assurance of the company's operational integrity and commitment to regulatory best practices.